Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1291-1300 Newer>

The Motley Fool July 7, 2004 Charly Travers	Pfizer Wants to Be Your Pfriend It seems that the pharmaceutical is limiting its profits in certain markets on its own terms in the hopes that concessions will be sufficient to keep from being handcuffed by Congress.
The Motley Fool July 7, 2004 Cam Goodwin	A Clever Growth Strategy So far, Accredo Health's maneuvers have proven to be successful and in its shareholders' best interests.
Information Today August 2004 Paula Hane	New Ovid/LWW CEO Brings a Fresh Look An interview with the president and CEO of Wolters Kluwer Health's global Medical Research division on the company's initiatives and some industry issues.
The Motley Fool July 6, 2004 Brian Gorman	Hidden Drug Costs Regulatory requirements play an important role in drug expenses.
The Motley Fool July 6, 2004 Brian Gorman	3M's Pharma Push 3M's Aldara may draw the firm into the drug manufacturers' blockbuster trap.
BusinessWeek July 12, 2004 Kerry Capell	These Biotechs Need Time To Ripen A rush to the IPO market in Europe won't do the biotech industry any good.
Reason July 2004 Caroline Waters	Bloody Shame Unnecessary regulations are making American blood banks run dry.
The Motley Fool July 2, 2004 Brian Gorman	Muscle in Wyeth's Pipeline An early stage Wyeth drug may have a better-than-average chance of approval.
The Motley Fool July 1, 2004 Brian Gorman	Charles River's Big Buy Charles River Laboratories is buying Inveresk Research Group in what appears to be a bid to control more of the burgeoning market for preclinical drug development services.
Managed Care June 2004 Martin Sipkoff	The New Consensus Favoring IOM's Definition of Quality The word "quality" is ubiquitous in health care, but what does it mean to health plan leaders, providers, patients, and payers?
<Older 1291-1300 Newer> Return to current articles.